Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-08-29
1996-08-20
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 530324, 530326, 530327, A61K 3800, C07K 710, C07K 708
Patent
active
055479375
ABSTRACT:
This invention discloses that certain fragments of a pulmonary surfactant protein exhibit unexpected surface activity. These protein fragments are useful in preparing formulations for the treatment of respiratory distress syndrome.
REFERENCES:
patent: 4234475 (1980-04-01), Sokol
patent: 4861756 (1991-01-01), Jackson
patent: 5055553 (1991-09-01), Jacobs et al.
patent: 5164369 (1992-06-01), Cochrane et al.
patent: 5238920 (1993-08-01), Sarin et al.
Glasser, et al, Proc. Natl. Acad. Sci., vol. 84, 1987, pp. 4007-4011.
"cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe)", Glasser et al, Biochemistry, vol. 84, 1987, pp. 4007-4011.
"Raman Spectroscopic Studies of Model Human Pulmonary Surfactant Systems: Phospholipid Interactions with Peptide Paradigms for the Sufactant Protein SP-B+", Vincent et al, Biochemistry, 1991 30, 8395-8401.
"Human surfactant polypeptide SP-B Disulfide bridges, C-terminal end, and peptide analysis of the airway form", Johansson et al, Elsevier Science Publishers B.V., vol. 301, No. 2, 165-167, 1992.
"Exogenous Surfactant for Human Lung Disease", Taeusch, et al. American Rev.Respiratory Diseases, vol. 128, 791-794, 1983.
"Biophysical and biological activity of a synthetic 8.7 kDa hydrophobic pulmonary surfactant protein SP-B", Proc. National Acad. Science, vol. 87, pp. 2633-2637, 1990.
"Pulmonary Surfactant Therapy", The New England Journal Of Medicine, Drug Therapy-Jobe, vol. 328, No. 12, pp. 861-868.
"Surfactant Chemical Composition and Biophysical Activity in Acute Respiratory Distress Syndrome", Gregory et al., The American Society For Clinical Investigation, Inc., vol. 88, pp. 1976-1981.
"Enzymic Inactivation of Oxytocin, III, Desthiooxytocin And S,S'-Debenzyldihydrooxytocin as Oxytocinase Inhibitors and Substrates", Berankova et al, Czechoslovak Academy of Science, vol. 26, pp. 2557-2561, 1961..
"Principles of Peptide Synthesis", M. Bodansky, D. Synthesis Of Cyclic Peptides, Springer-Veriag, p. 223.
"Conformation of Biopolymers", Ramachandran, Academic Press Inc. (London) Ltd., vol. 1, pp. 215-216, 1967.
"The Role of Sulfur in Proteins", Liu, The Proteins, vol. III, pp. 239 and 255, 1977.
"Preparation of S,S'-Dibenzyloxytocin and Its Reconversion to Oxytocin", Gordon, et al, P.S.E.B.M., V. 84, 1953.
Absolom Darryl R.
Baxter Constance H.
Dhaon Madhup K.
Lundell Edwin O.
Sarin Virender K.
Abbott Laboratories
Brainard Thomas D.
Marshall S. G.
Nickey Donald O.
Weimar Elizabeth C.
LandOfFree
Pulmonary surfactant protein fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pulmonary surfactant protein fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary surfactant protein fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330798